Abstract
Candida albicans (C. albicans) is a ubiquitous commensal in the mammalian flora and the most prevalent fungal pathogen of humans. As an opportunistic fungus, C. albicans can cause mucosal and invasive infections. Invasive candidiasis infected by C. albicans is a leading cause of perioperative death in immunocompromised and immunodeficient patients. The morphological change from the yeast to the mycelium plays a key role in the pathogenesis of C. albicans. C-type lectin receptors (CLRs), including Dectin-1, Dectin-2, Dectin-3, Mincle, and dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin, are among the pattern recognition receptors expressed by innate immune cells that can recognize C. albicans. The emergence of drug-resistant C. albicans put pressure on the healthcare system, whereby CLRs have also attracted extensive attention from physicians. Thus, in this article, we discuss the interaction between CLRs and C. albicans and the treatment prospects of CLRs on anti-C. albicans.
Publisher
Zentime Publishing Corporation Limited
Reference117 articles.
1. Invasive candidiasis;Pappas;Nat Rev Dis Primers,2018
2. Beta-glucan exposure on the fungal cell wall tightly correlates with competitive fitness of candida species in the mouse gastrointestinal tract;Sem;Front Cell Infect Microbiol,2016
3. Looking into Candida albicans infection, host response, and antifungal strategies;Wang;Virulence,2015
4. [4] Zhou Y, Yu F, Yu Y, et al. Clinical significance of MDRO screening and infection risk factor analysis in the ICU. Am J Transl Res 2021;13(4):3717-3723.
5. [5] Ahmad S, Kumar S, Rajpal K, et al. Candidemia Among ICU Patients: Species Characterisation, Resistance Pattern and Association With Candida Score: A Prospective Study. Cureus 2022;14(4):e24612.